期刊文献+

Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells 被引量:16

Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells
下载PDF
导出
摘要 Background: Radiotherapy is one of the main therapeutic approaches for non–small cell lung cancer(NSCLC). However, radioresistant cancer cells can eventually cause tumor relapse and even fatal metastasis. It is thought that radioresistance and metastasis could be potentially linked by epithelial?mesenchymal transition(EMT). In this study, we established radioresistant NSCLC cells to investigate the potential relationship among radioresistance, EMT, and enhanced metastatic potential and the underlying mechanism involving liver kinase B1(LKB1)?Salt?inducible kinase 1(SIK1) signaling.Methods: The radioresistant cell lines A549 R and H1299 R were generated by dose?gradient irradiation of the paren?tal A549 and H1299 cells. The radioresistance/sensitivity was evaluated by Cell Counting Kit?8 assay, apoptosis analysis, and/or clonogenic cell survival assay. The EMT phenotype and the signaling change were assessed by Western blot?ting. The abilities of invasion and migration were evaluated by transwell assays and wound healing assays.Results: The radioresistant cell lines A549 R and H1299 R displayed mesenchymal features with enhanced invasion and migration. Mechanistically, A549 R and H1299 R cells had attenuated LKB1?SIK1 signaling, which leaded to the up?regulation of Zinc?finger E?box?binding homeobox factor 1(ZEB1)—a transcription factor that drives EMT. Re?expression of LKB1 in A549 R cells reversed the EMT phenotype, whereas knockdown of LKB1 in H1299 R cells further promoted the EMT phenotype. Moreover, re?expression of LKB1 in A549 cells increased the radiosensitivity, whereas knockdown of LKB1 in H1299 cells decreased the radiosensitivity.Conclusions: Our findings suggest that attenuated LKB1?SIK1 signaling promotes EMT and radioresistance of NSCLC cells, which subsequently contributes to the enhanced metastatic potential. Targeting the LKB1?SIK1?ZEB1 pathway to suppress EMT might provide therapeutic benefits. Background: Radiotherapy is one of the main therapeutic approaches for non–small cell lung cancer(NSCLC). However, radioresistant cancer cells can eventually cause tumor relapse and even fatal metastasis. It is thought that radioresistance and metastasis could be potentially linked by epithelial-mesenchymal transition(EMT). In this study, we established radioresistant NSCLC cells to investigate the potential relationship among radioresistance, EMT, and enhanced metastatic potential and the underlying mechanism involving liver kinase B1(LKB1)-Salt-inducible kinase 1(SIK1) signaling.Methods: The radioresistant cell lines A549 R and H1299 R were generated by dose-gradient irradiation of the paren-tal A549 and H1299 cells. The radioresistance/sensitivity was evaluated by Cell Counting Kit-8 assay, apoptosis analysis, and/or clonogenic cell survival assay. The EMT phenotype and the signaling change were assessed by Western blot-ting. The abilities of invasion and migration were evaluated by transwell assays and wound healing assays.Results: The radioresistant cell lines A549 R and H1299 R displayed mesenchymal features with enhanced invasion and migration. Mechanistically, A549 R and H1299 R cells had attenuated LKB1-SIK1 signaling, which leaded to the up-regulation of Zinc-finger E-box-binding homeobox factor 1(ZEB1)—a transcription factor that drives EMT. Re-expression of LKB1 in A549 R cells reversed the EMT phenotype, whereas knockdown of LKB1 in H1299 R cells further promoted the EMT phenotype. Moreover, re-expression of LKB1 in A549 cells increased the radiosensitivity, whereas knockdown of LKB1 in H1299 cells decreased the radiosensitivity.Conclusions: Our findings suggest that attenuated LKB1-SIK1 signaling promotes EMT and radioresistance of NSCLC cells, which subsequently contributes to the enhanced metastatic potential. Targeting the LKB1-SIK1-ZEB1 pathway to suppress EMT might provide therapeutic benefits.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2016年第10期500-508,共9页
基金 supported by grants from the Jiangsu Provincial Department of Human Resources and Social Security under the“Six Talent Peaks”Project(No.2013-WSN-082) the Jiangsu Provincial Commission of Health and Family Planning under the Project of Science and Technology(No.H201426)
关键词 放射敏感性 肺癌细胞 信号 间质 转化 上皮 减毒 非小细胞肺癌 Radioresistance Lung cancer Metastasis Epithelial-mesenchymal transition LKB1 SIK1
  • 相关文献

参考文献2

二级参考文献15

  • 1Jimenez AI, Fernandez R Dominguez O, DopazoA, Sanchez-Cespedes M. Growth and molecular profile of lung cancer cells expressing ectopic LKB 1: down-regulation of the phosphatidylinositol 3-phosphate kinase/PTEN pathway. Cancer Res 2003; 63: 1382-1388.
  • 2Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010; 10: 165-180.
  • 3Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
  • 4Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM. Enhanced expression of LKBI in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res 2006; 4: 843-849.
  • 5Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010; 29: 223-237.
  • 6Bruchim I, Attias Z, Werner H. Targeting the IGFI axis in cancer proliferation. Expert Opin Ther Targets 2009; 13: 1179-1192.
  • 7Hemminki A, Markie D, Tomlinson 1, Avizienyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184-187.
  • 8Giardiello P-M, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-1453.
  • 9Lim W, Hearle N, Shah B, Murday V, Hodgson SV, Lucassenet A, et al. Further observations on LKB1/STKII status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer 2003; 89: 308-313.
  • 10Sanchez-Cespedes M, Parrella E Esteller M, Nomoto S, Trink B, Engles J M, et al. Inactivation of LKBI/STKI 1 is a common event in adenocarcinomas of the lung. Cancer Res 2002; 62: 3659-3662.

共引文献119

同被引文献65

引证文献16

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部